Letter re: Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France
- PMID: 36870191
- DOI: 10.1016/j.ejca.2023.01.026
Letter re: Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France
Conflict of interest statement
Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France.Eur J Cancer. 2020 Jan;124:37-46. doi: 10.1016/j.ejca.2019.09.028. Epub 2019 Nov 9. Eur J Cancer. 2020. PMID: 31715555
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources